Expression and Significance of MTA2 and CPNE1 in Cervical Squamous Cell Carcinoma

Appl Immunohistochem Mol Morphol. 2023 Sep 1;31(8):569-573. doi: 10.1097/PAI.0000000000001138. Epub 2023 Jul 3.

Abstract

The aim of this study was to investigate the expression and clinical significance of MTA2 and CPNE1 proteins in cervical squamous cell carcinoma. In this study, high-risk human papillomavirus (HPV) typing was performed on cervical cancer tissues. Reverse transcription polymerase chain reaction and immunochemical EliVision method were used to examine the expressions of MTA2 and CPNE1 in the cervix, and their relationship with clinicopathologic features. We found that it is mainly distributed in these types, namely HPV-16 (23.8%), HPV-18 (20.9%), HPV-53 (17.1%), HPV-52 (15.5%), HPV-82 (11.7%), HPV-56 (10.8%). The expressions of MTA2 and CPNE1 in cervical squamous cell carcinoma tissues were significantly higher than those in normal tissues ( P <0.01). The expressions of MTA2 and CPNE1 were correlated with FIGO stage, degree of differentiation, and lymph node metastasis of cervical cancer ( P <0.05), but not with the patient's age ( P >0.05). The rank correlation coefficient of MTA2 and CPNE1 protein expression in cervical squamous cell carcinoma was 0.668 ( P <0.01), and the 2 expressions were positively correlated. MTA2 and CPNE1 are closely related to the occurrence and development of cervical squamous cell carcinoma and may play a synergistic role in the evolution of cervical squamous cell carcinoma.

MeSH terms

  • Carcinoma, Squamous Cell* / pathology
  • Female
  • Histone Deacetylases
  • Humans
  • Papillomavirus Infections* / metabolism
  • Repressor Proteins
  • Uterine Cervical Neoplasms* / pathology

Substances

  • MTA2 protein, human
  • Histone Deacetylases
  • Repressor Proteins

Supplementary concepts

  • human papillomavirus 52
  • human papillomavirus 56